ENLV Stock Analysis: Buy, Sell, or Hold?
ENLV - Enlivex Therapeutics Ltd. Ordinary Shares
$1.09
0.05 (4.81%)
▲
5d:
-9.17%
30d:
+44.39%
90d:
+3.81%
HOLD
LOW Confidence
Last Updated: February 3, 2026
Earnings: Feb 25, 2026
20d
Get Alerted When ENLV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ENLV shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ENLV shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ENLV is currently trading at $1.09, which is considered extended relative to its 30-day fair value range of $0.80 to $1.08.
Technical Outlook: Technically, ENLV is in a downtrend. Immediate support is located at $0.92, while resistance sits at $1.26. The stock is showing strong short-term momentum, up 4.8% recently.
Market Sentiment: ENLV has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $13.00 (+1092.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ENLV is in a downtrend. Immediate support is located at $0.92, while resistance sits at $1.26. The stock is showing strong short-term momentum, up 4.8% recently.
Market Sentiment: ENLV has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $13.00 (+1092.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$0.80 -
$1.08
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
68.4%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.8%)
- BULLISH: Trading 1092.7% below Wall St target ($13.00)
- CAUTION: Recommendation downgraded due to -9.2% 5-day decline
Fair Price Analysis
30-Day Fair Range
$0.80 -
$1.08
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$0.92
Resistance Level
$1.26
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-3.41
Wall Street Target
$13.00
(+1092.7%)
Last updated: February 04, 2026 7:29 AM ET
Data refreshes hourly during market hours. Next update: 8:29 AM
Data refreshes hourly during market hours. Next update: 8:29 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ENLV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 51 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$215 | 58 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
BUY
20 analysts |
$31 | 60 BUY |
|
ORIC
Oric Pharmaceuticals Inc |
STRONG BUY
12 analysts |
$21 | 58 HOLD |
|
VERA
Vera Therapeutics Inc |
STRONG BUY
14 analysts |
$75 | 54 HOLD |
